期刊文献+

尿毒症患者的中药结肠透析联合血液透析研究 被引量:2

Study on traditional Chinese medicine colon dialysis combined with hemodialysis for patients with uremia
下载PDF
导出
摘要 目的观察尿毒症患者应用中药结肠透析联合血液透析治疗后的效果。方法采用随机数字表法将本院89例尿毒症患者分为2组。2组患者均给予基础对症治疗,对照组44例患者增加血液透析进行治疗,观察组45例患者在对照组基础上接受中药结肠透析治疗。比较2组患者治疗后肾功能、炎症因子水平、毒素水平变化。结果观察组治疗后尿素氮(BUN)、血清肌酐(Scr)、血清尿酸(UA)、C反应蛋白(CRP)、白细胞介素-6 (IL-6)、肿瘤坏死因子-α(TNF-α)、甲状旁腺素(PTH)、β2-微球蛋白(β2-MG)及硫酸吲哚酚(IS)水平均显著低于对照组(P <0.05)。结论中药结肠透析联合血液透析能够有效改善尿毒症患者的炎症状态,降低尿毒症毒素水平,改善肾功能。 Objective To observe the effect of traditional Chinese medicine colon dialysis combined with hemodialysis for patients with uremia.Methods Eighty-nine patients with uremia in our hospital were divided into two groups by random number table method,and were given basic symptomatic treatment.The control group(n=44)was treated by hemodialysis,while the observation group(n=45)was treated by colonic dialysis based on the control group.Changes in renal function,inflammatory factor levels,and toxin levels were observed after treatment.Results The levels of blood urea nitrogen(BUN),serum creatinine(Scr),serum uric acid(UA),C-reactive protein(CRP),interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),parathyroid hormone(PTH),β2-microglobulin(β2-MG)and indoxol sulfate(IS)in the observation group were lower than those in the control group after treatment(P<0.05).Conclusion Traditional Chinese medicine colon dialysis combined with hemodialysis can effectively improve the inflammatory status of uremic patients,reduce the level of uremic toxins,and improve renal function.
作者 张矿军 张盼盼 孙丹丹 ZHANG Kuangjun;ZHANG Panpan;SUN Dandan(Department of Nephrology and Rheumatology,Hebi City People′s Hospital in Henan Province,Hebi,Henan,458030;Department of Emergency,Hebi City People′s Hospital in Henan Province,Hebi,Henan,458030)
出处 《实用临床医药杂志》 CAS 2020年第22期44-46,共3页 Journal of Clinical Medicine in Practice
关键词 中药结肠透析 血液透析 尿毒症 炎症因子 Chinese medicine colon dialysis hemodialysis uremia inflammatory factors
  • 相关文献

参考文献9

二级参考文献63

  • 1赖寒,甘华.血液透析患者预后的研究进展[J].中华临床医师杂志(电子版),2011,5(9):2677-2679. 被引量:14
  • 2安海燕,任可.补骨汤治疗肾性骨病的临床观察[J].中国中西医结合肾病杂志,2004,5(12):718-719. 被引量:13
  • 3Jha V, Garcia - Garcia G, Iseki K, et al. Chronic kidney disease : global dimension and perspectives. Lancet, 2013,382 ( 9888 ) : 260 - 272.
  • 4Yu X, Fang Y, Liu H, et al. The balance of beneficial and delete- rious effects of hypoxia - inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the tim- ing of administration. Nephrol Dial Transplant, 2012,27 ( 8 ) : 3110 -3119.
  • 5Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phos- phorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney dis- ease : a systematic review and meta - analysis. JAMA, 2011,305 (11) :1119 -1127.
  • 6Eto N ,Tomita M, Hayashi M. NaPi -mediated transcellular per- meation is the dominant route in intestinal inorganic phosphate absorption in rats. Drug Metab Pharmacokinet ,2006,21 (3) :217 - 221.
  • 7Sabbagh Y, O' Brien SP, Song W, et al. Intestinal npt2b plays a major role in phosphate absorption and homeostasis. J Am Soc Nephrol,2009,20( 1 ) :2348 - 2358.
  • 8Miyamoto K, Ito M, Kuwahata M, et al. Inhibition of intestinal so- dium - dependent inorganic phosphate transport by fibroblast growth factor 23. Ther Apher Dial,2005,9 (4) : 331 - 335.
  • 9Kalantar - Zadeh K, Ikizler TA, Block G, et al. Malnutrition - in- flammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis ,2003,42 (5) :864- 881.
  • 10Arenas M D,de la Fuente V,Delgado P,et al.Pharmacodynamics of cinacalcet over 48 hours in patients with controlled secondary hyperparathyroidism:useful data in clinical practi-ce. The Journal of Clinical Endocrinology . 2013

共引文献79

同被引文献27

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部